The Prognostic Value of Androgenetic Alopecia and Benign Prostatic Hyperplasia in Men with COVID-19: A Prospective Multidisciplinary Observational Study of 766 Patients from Turkey

October 2022 in “ Journal of health sciences and medicine ”

Çağrı Turan, Nurcan Metin, Türkantuğba YILDIZ>, Selcen CAFEROĞLU SKAT>, Ahmet Emre Cinislioglu, Nazan CİNİSLİOĞLU

androgenetic alopecia benign prostatic hyperplasia Gabrin sign androgen-mediated COVID-19 severity hypothesis AGA BPH

TLDR Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

This study evaluated 766 men with COVID-19 in Turkey to assess the prognostic value of androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). The study found no significant prognostic value of AGA in younger patients, but middle-aged and elderly patients with the Gabrin sign showed poorer outcomes in terms of oxygen saturation and lymphocyte count. Although AGA was not a significant prognostic indicator, hospitalization rates were notably higher in middle-aged and elderly patients with BPH, suggesting a potential link to the androgen-mediated COVID-19 severity hypothesis. However, no significant relationship was found between BPH and ICU transfer or mortality.

View this study on dergipark.org.tr →

Discuss this study in the Community →

Research cited in this study

8 / 8 results

Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign

research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign

32 citations , July 2020 in “Journal of The American Academy of Dermatology”

AGA linked to worse COVID-19 outcomes in men.

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

119 citations , May 2020 in “Journal of The American Academy of Dermatology”

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

research Androgen Sensitivity Gateway to COVID-19 Disease Severity

123 citations , May 2020 in “Drug Development Research”

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

research Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

71 citations , April 2020 in “Journal of Cosmetic Dermatology”

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

research A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

134 citations , April 2020 in “Journal of Cosmetic Dermatology”

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

research The Relation Between Androgenetic Thin Hair Diagnosed by Trichoscope and Benign Prostatic Hyperplasia

1 citations , December 2018 in “Journal of Cosmetic Dermatology”

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

research The Role of Androgen and Androgen Receptor in Skin-Related Disorders

124 citations , July 2012 in “Archives of Dermatological Research”

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

155 citations , December 2003 in “British Journal of Dermatology”

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Similar Research

5 / 1000+ results

research SARS-CoV-2 Vaccination in Androgen Sensitive Phenotypes – A Study on Associated Factors for SARS-CoV-2 Vaccination and Its Adverse Effects Among Androgenetic Alopecia and Benign Prostate Hyperplasia Patients

September 2022 in “Frontiers in Immunology”

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Is COVID-19 a Risk Factor for Progression of Benign Prostatic Hyperplasia and Exacerbation of Its Related Symptoms?: A Systematic Review

research Is COVID-19 a Risk Factor for Progression of Benign Prostatic Hyperplasia and Exacerbation of Its Related Symptoms?: A Systematic Review

21 citations , May 2021 in “Prostate Cancer and Prostatic Diseases”

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

research Sex Hormones in SARS-CoV-2 Susceptibility: Key Players or Confounders?

8 citations , December 2022 in “Nature Reviews Endocrinology”

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

research Impact of Androgen Status and Anti-Androgen Therapy on the Course of COVID-19 in Men

October 2020 in “Проблемы эндокринологии”

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

research Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics

17 citations , November 2021 in “Journal of Cosmetic Dermatology”

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

The Prognostic Value of Androgenetic Alopecia and Benign Prostatic Hyperplasia in Men with COVID-19: A Prospective Multidisciplinary Observational Study of 766 Patients from Turkey

Research cited in this study

research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

research Androgen Sensitivity Gateway to COVID-19 Disease Severity

research Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

research A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

research The Relation Between Androgenetic Thin Hair Diagnosed by Trichoscope and Benign Prostatic Hyperplasia

research The Role of Androgen and Androgen Receptor in Skin-Related Disorders

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

Related Community Posts Join

community 1 month of using fin, so happy

community Sexual Dysfunction in Those with Androgenetic Alopecia on Dutasteride Versus Finasteride

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

community New and Interesting HairLoss Studies/Papers/Reviews

community Testosterone and Estradiol levels on 1 mg/day dutasteride